摘要
目的:分析营养干预联合药物治疗在老年原发性骨质疏松中的应用价值。方法:选择在本院接受治疗的老年原发性骨质疏松患者作为研究对象,随机分为单纯接受药物治疗的对照组及接受营养干预联合药物治疗的观察组,比较两组患者干预前后骨密度、血钙磷及碱性磷酸酶水平、腰背痛VAS评分等差异。结果:(1)两组患者接受干预后的骨密度均上升,但观察组患者的骨密度值明显高于对照组患者(P<0.05);(2)观察组患者接受干预后的血钙水平明显高于对照组患者,血鳞及碱性磷酸酶水平明显低于对照组患者(P<0.05);(3)观察组接受干预后的腰背部中重度疼痛患者比例明显低于对照组(P<0.05)。结论:营养干预联合药物可以有效提高老年原发性骨质疏松患者的骨密度及血钙水平,降低血鳞及碱性磷酸酶水平,缓解腰背部疼痛,具有积极的临床意义。
Objective： To analyze the Effect of nutrition combine drug interventions on elderly with primary osteoporosis. Methods：Choosed old patients with primary osteoporosis in our hospital as research subjects,randomly divided into control group receiving drug therapy alone and observation group receiving nutrition interventions combined with drug treatment,compared bone density,blood calcium and phosphorus and alkaline phosphatase levels,low back pain VAS scores.Results：（1）Observation group patients’ bone mineral density after intervention were increased,but bone mineral density of the observation group were significantly higher than control group patients （P〈0.05）;（2）Observation group patients’ serum calcium levels were significantly higher than control group,serum alkaline phosphatase levels were significantly lower than control group patients （P〈0.05）;（3）Observation group patients’ severe lower back proportion after intervention was significantly lower than control group patients（P〈0.05 ）.Conclusion：The combination of drugs nutritional intervention can improve bone density and calcium levels in elderly patients with primary osteoporosis,lower blood scales and alkaline phosphatase levels,relieve back pain,with positive clinical significance.
出处
《中国医药导刊》
2015年第6期627-629,共3页
Chinese Journal of Medicinal Guide
关键词
原发性骨质疏松
营养干预
骨密度
Primary osteoporosis
Nutritional intervention
Bone density
